ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet‐derived growth factor BB
Cited by 60
Related Papers
Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
|Cell Death and Disease|2020|75
MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF
|Cancer Cell International|2015|57
Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway
|Oncotarget|2016|34
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
|Journal of Clinical Investigation|2023|29